Mometasone-17,20-Difuroate

Simultaneous determination of Mometasone Furoate and Benzalkonium Chloride-​A stability indicating method
By Kulkarni, Pankaj N.; Dodake-Supekar, Alaknanda M.; Gill, Charansingh H.
From Rasayan Journal of Chemistry (2020), 13(3), 1522-1530
 
Simultaneous estimation and validation of terbinafine hydrocloride and mometasone furoate in bulk and pharmaceutical dosage form by using RP-​HPLC
By Khatik, Dipak P.; Lawre, R. B.; Mankar, S. D.
From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(6), 1264-1274
 
Study of Intrinsic Stability of Mometasone Furoate in Presence of Salicylic Acid by HPTLC and Characterization, Cytotoxicity Testing of Major Degradation Product of Mometasone Furoate
By Vichare, Vijaya; Choudhari, Vishnu P.; Reddy, M. Venkata
From Current Pharmaceutical Analysis (2019), 15(6), 592-603

Mometasone-17,20-Difuroate is chemically (E)-2-Chloro-1-((8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-((furan-2-carbonyl)oxy)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)vinyl furan-2-carboxylate. Mometasone-17,20-Difuroate is supplied with detailed characterization data compliant with regulatory guideline. Mometasone-17,20-Difuroate can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Mometasone .

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.